EUROPEAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS LIMITED
Financial health, per its FY2024 accounts
Per the auditor's report, the financial statements were subject to an independent audit which identified significant risks related to the completeness of income recognition and potential management override of controls. The auditor confirmed that their work was limited to providing an opinion to the members and did not assume responsibility to other parties. The document does not disclose specific financial health metrics such as reserves or surplus/deficit figures.
What the accounts disclose
“We identified the greatest risk of material impact on the financial statements from irregularities, including fraud, to be within the completeness of recognition of Independent Medical Education income, congress income from exhibition and sponsorship and the override of controls by management.” — page 19
Structured financials (annual return, FY ending 31/12/2024)
Trustees
- JOSE GUELL
- PAUL ROSEN
- Professor John Bateson
- ROBERTO BELLUCCI
- Till Staffeldt
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £19.2m | £16.5m |
| 31/12/2023 | £16.1m | £16.0m |
| 31/12/2022 | £11.6m | £11.7m |
| 31/12/2021 | £6.7m | £9.0m |
| 31/12/2020 | £4.3m | £8.5m |
Common questions
Is EUROPEAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS LIMITED financially healthy?
Per the auditor's report, the financial statements were subject to an independent audit which identified significant risks related to the completeness of income recognition and potential management override of controls. The auditor confirmed that their work was limited to providing an opinion to the members and did not assume responsibility to other parties. The document does not disclose specific financial health metrics such as reserves or surplus/deficit figures. Its FY2024 accounts were audited by Crowe U.K. LLP.